In terms of a takeover, am I right in thinking we will get 2 phase 2 top-line results (P-Hopkins and Angelmans) within 2 weeks of each other in late March? Hard to see anything happening before that? That will be a pretty monumentous fortnight!! I think if they are both positive then NNZ-2591 will pretty much have proof of concept as a treatment in ASD. I attach a link to an interesting recent paper about, at least in part, aetiology of ASD. It really reinforces Neuren's strategy with ASD as an end-game, IMO.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915249/
Potential Takeover, page-19
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.50 |
Change
0.190(0.98%) |
Mkt cap ! $2.490B | |||
| Open | High | Low | Value | Volume |
| $19.39 | $19.98 | $19.38 | $7.285M | 370.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 7318 | $19.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.52 | 593 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.55 |
Change
0.190 ( 0.83 %) |
||||
| Open | High | Low | Volume | ||
| $19.41 | $19.97 | $19.39 | 83274 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| NEU (ASX) Chart |